Heights Capital Ireland, LLC 17 June 2024 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN...
Stifel Nicolaus Europe Limited 17 June 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED...
Renalytix PLC on Friday said Medicare had issued a final local coverage determination for its kidney testing kit, kid ...
LONDON and NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX...
Stifel Nicolaus Europe Limited 14 June 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED...
Renalytix PLC 14 June 2024 This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU...
Heights Capital Ireland, LLC 14 June 2024 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN...
Stifel Nicolaus Europe Limited 13 June 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED...
Renalytix PLC 13 June 2024 Renalytix plc ("Renalytix" or the "Company") PDMR Dealing LONDON and SALT LAKE CITY, 13 June 2024 - Renalytix...
Heights Capital Ireland, LLC 13 June 2024 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN...
Stifel Nicolaus Europe Limited 12 June 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED...
Heights Capital Ireland, LLC 12 June 2024 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN...
Stifel Nicolaus Europe Limited 11 June 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED...
Heights Capital Ireland, LLC 11 June 2024 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.